HISTOPATHOLOGICAL AND MOLECULAR MECHANISMS OF ATHEROSCLEROSIS DEVELOPMENT AND PROGRESSION

Authors

  • Saydullayev T. Andijan State Medical Institute, Uzbekistan

Keywords:

atherosclerosis, histopathology, endothelial dysfunction, low-density lipoproteins, foam cells, vascular inflammation, smooth muscle cells, fibrous plaque, cardiovascular disease

Abstract

Atherosclerosis is a chronic inflammatory disease of medium-sized and large arteries characterized by lipid accumulation, endothelial dysfunction, inflammatory cell infiltration, and progressive structural remodeling of the vascular wall. The development of atherosclerotic lesions involves complex interactions between circulating lipoproteins, vascular endothelial cells, smooth muscle cells, macrophages, and extracellular matrix components. This article examines the histopathological and molecular mechanisms underlying the initiation, progression, and complications of atherosclerosis. Particular attention is devoted to endothelial dysfunction, low-density lipoprotein retention and modification, foam cell formation, vascular smooth muscle cell phenotypic changes, and fibrous plaque development. The study is based on a narrative analysis of established scientific literature using descriptive, comparative, and morphological-functional approaches. The findings indicate that atherosclerosis is not simply a consequence of lipid deposition but represents a dynamic inflammatory and fibroproliferative process. Plaque vulnerability is influenced by the composition of the fibrous cap, inflammatory activity, lipid-rich necrotic core, and local vascular conditions. Understanding the cellular and histological mechanisms of atherosclerosis is essential for improving cardiovascular risk assessment, prevention, and therapeutic strategies.

References

Libby, P. (2021). The changing landscape of atherosclerosis. Nature, 592, 524–533.

Ross, R. (1999). Atherosclerosis — An inflammatory disease. The New England Journal of Medicine, 340(2), 115–126.

Lusis, A. J. (2000). Atherosclerosis. Nature, 407, 233–241.

Hansson, G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine, 352(16), 1685–1695.

Tabas, I., García-Cardeña, G., & Owens, G. K. (2015). Recent insights into the cellular biology of atherosclerosis. The Journal of Cell Biology, 209(1), 13–22.

Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014). Mechanisms of plaque formation and rupture. Circulation Research, 114(12), 1852–1866.

Gimbrone, M. A., Jr., & García-Cardeña, G. (2016). Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circulation Research, 118(4), 620–636.

Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013). Macrophages in atherosclerosis: A dynamic balance. Nature Reviews Immunology, 13, 709–721.

Ference, B. A., Ginsberg, H. N., Graham, I., et al. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. European Heart Journal, 38(32), 2459–2472.

Downloads

Published

2026-11-04

How to Cite

Saydullayev T. (2026). HISTOPATHOLOGICAL AND MOLECULAR MECHANISMS OF ATHEROSCLEROSIS DEVELOPMENT AND PROGRESSION. IQRO , 24(02), 64–70. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/9772